27
NPS Score
VS
Bristol Myers Squibb
- EMPLOYEE
PARTICIPANTS - 261
- TOTAL
RATINGS
Karyopharm Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 90
- TOTAL
RATINGS
Bristol Myers Squibb vs Karyopharm Therapeutics
Compare Bristol Myers Squibb versus Karyopharm Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 261 employees and customers of Bristol Myers Squibb and 90 employees and customers of Karyopharm Therapeutics.
Bristol Myers Squibb
Bristol Myers Squibb's brand is ranked #205 in the list of Global Top 1000 Brands, as rated by customers of Bristol Myers Squibb. Their current market cap is $140.58B.
Karyopharm Therapeutics
Karyopharm Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Karyopharm Therapeutics. Their current market cap is $753.30M.
3.9/5
Product Quality
5/5
3.7/5
Pricing
5/5
3.8/5
Customer Service
5/5
| 55% | Promoters |
|---|---|
| 17% | Passive |
| 28% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 73
See how Bristol Myers Squibb compares to its competitors
See how Karyopharm Therapeutics compares to its competitors
Working at Bristol Myers Squibb vs Working at Karyopharm Therapeutics
78 / 100
CEO Rating
82 / 100
CEO Rating
Winner by 4%
Bristol Myers Squibb
Bristol Myers Squibb doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Karyopharm Therapeutics
Employees at Karyopharm Therapeutics rate their CEO, Richard Paulson, 82/100. This score is 4% higher than the scores of Bristol Myers Squibb's CEO, Giovanni Caforio. Employees in the IT and Sales departments rate Richard Paulson the highest.